C07D 277/04
Having no double bonds between ring members or between ring members and
Official title: having no double bonds between ring members or between ring members and non-ring members
C07D277/04 (Having no double bonds between ring members or between ring members and) appears on 547 US grants and 336 published applications in this corpus.
Search patents in C07D- Granted patents
- 547
- Published applications
- 336
- Assignees
- 280
- Inventors
- 1,407
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 11 | 0 |
| 1978 | 20 | 0 |
| 1979 | 7 | 0 |
| 1980 | 18 | 0 |
| 1981 | 14 | 0 |
| 1982 | 14 | 0 |
| 1983 | 13 | 0 |
| 1984 | 21 | 0 |
| 1985 | 9 | 0 |
| 1986 | 10 | 0 |
| 1987 | 16 | 0 |
| 1988 | 12 | 0 |
| 1989 | 14 | 0 |
| 1990 | 11 | 0 |
| 1991 | 8 | 0 |
| 1992 | 12 | 0 |
| 1993 | 10 | 0 |
| 1994 | 7 | 0 |
| 1995 | 29 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 13 | 8 |
| 2002 | 11 | 17 |
| 2003 | 15 | 23 |
| 2004 | 10 | 32 |
| 2005 | 13 | 31 |
| 2006 | 18 | 19 |
| 2007 | 18 | 21 |
| 2008 | 14 | 17 |
| 2009 | 10 | 17 |
| 2010 | 15 | 19 |
| 2011 | 7 | 13 |
| 2012 | 10 | 11 |
| 2013 | 9 | 10 |
| 2014 | 9 | 16 |
| 2015 | 10 | 10 |
| 2016 | 5 | 6 |
| 2017 | 10 | 8 |
| 2018 | 11 | 8 |
| 2019 | 5 | 11 |
| 2020 | 10 | 9 |
| 2021 | 6 | 6 |
| 2022 | 2 | 7 |
| 2023 | 3 | 8 |
| 2024 | 0 | 4 |
| 2025 | 2 | 5 |
| 2026 | 4 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for gamma-glutamyl cycle modulation21 Jul 2026US 12,686,667 B2Cancer Research Technologies Limited
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Compositions and methods of treatment for neurological disorders comprising depression7 Oct 2025US 12,433,892 B2Gliapharm SA
- Pharmaceutical for the inhibition of cellular proton pumps30 Oct 2025US 2025/0333389 A1
- Small molecule antagonists of pf411 Sep 2025US 2025/0281424 A1Fox Chase Chemical Diversity Center, Inc.
- Crystalline form of leucogen and method for preparation thereof and use thereof5 Jun 2025US 2025/0179037 A1Jiangsu Jibeier Pharmaceutical Co. Ltd.
- Method of inhibiting tau phosphorylation22 May 2025US 2025/0163372 A1Cassava Sciences, Inc.
- Method of inhibiting tau phosphorylation20 Mar 2025US 2025/0092361 A1Cassava Sciences, Inc.
Most cited
By later US patents
- Effectors of dipeptidyl peptidase IV135US 6,548,481 B1Probiodrug AG · 2003
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Amino acid derivatives100US 5,157,041 AHoffmann-La Roche Inc. · 1992
- Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods92US 6,995,183 B2Bristol-Myers Squibb Company · 2006
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996